Furthermore, Lp-PLA2 silencing resulted in the downregulation of the expression of p-JAK2/JAK2 and p-STAT3/STAT3 in NASH mice. The gene discussed is JAK2; the disease is metabolic dysfunction-associated steatohepatitis.